Arysta LifeScience Suspends MIDAS In U.S.
Company says decision to pull fumigant based on economic viability.
Arysta LifeScience Corp. announced the immediate suspension product sales for all formulations of the fumigant MIDAS (iodomethane, chloropicrin). The announcement is limited to MIDAS and applies to no other product the company markets.
The decision was made as part of an internal review of the fumigant and based on its economic viability in the U.S. marketplace.
“Arysta LifeScience remains committed to growers through our many other products,” said Amy Yoder, Head of Arysta LifeScience North American Business Unit. “We will continue to develop and bring to market innovative solutions for growers in the crop protection market.”
The company would like to express its gratitude to growers, researchers, business partners and supporters who helped MIDAS achieve U.S. EPA registration and registration in 48 states.
Arysta LifeScience will continue to support the use of iodomethane outside of the U.S. where it remains economically viable.
Source: Arysta LifeScience
Comments (0)
